FDA Regulation of Medical Devices: A Primer for EU Startups
The FDA uses a different framework than the MDR. Here is the primer for EU founders who want to understand what US market access actually requires.
Category
FDA & International Market Access
45 in-depth guides in this cluster
FDA vs. MDR: Fundamental Differences in Medical Device Regulation
The structural differences between FDA and EU MDR — regulation vs guidance, notified body vs agency, classification logic, evidence and post-market philosophy.
FDA Device Classification: Class I, II, and III Explained for EU Startups
FDA classifies devices as Class I, II, or III by risk and pathway. Here is how the FDA classification compares to MDR for EU founders considering US entry.
The 510(k) Process Explained: How to Get FDA Clearance for Your Device
The FDA 510(k) pathway is how most medical devices reach the US market. Here is the process explained at a level useful for EU startups considering US entry.
Substantial Equivalence Under 510(k): Predicate Device Strategy for EU Startups
FDA 510(k) clearance depends on substantial equivalence to a predicate device. Here is how EU startups should think about predicate selection.
De Novo Classification Under FDA: The Path for Novel Low-to-Moderate Risk Devices
The FDA De Novo pathway is for novel devices that have no predicate but moderate risk. Here is the pathway at general framing for EU startups.
PMA Under FDA: The Highest Bar for Medical Devices
FDA PMA premarket approval explained for EU founders: what triggers it, evidence demands, timelines, fees, and how it compares to MDR Class III.
FDA 510(k) vs. MDR CE Marking: A Side-by-Side Comparison for Startups
A side-by-side comparison of FDA 510(k) clearance and MDR CE marking: classification, evidence, QMS, timeline, and cost for EU startups targeting both.
Dual Submission Strategy: Pursuing CE Mark and FDA Clearance Simultaneously
Pursuing CE marking and FDA clearance simultaneously can save time but doubles the work. Here is the dual submission strategy for EU MedTech startups.
FDA Establishment Registration for EU Manufacturers
FDA establishment registration EU manufacturers guide: who must register, fees, US Agent rules, device listing, UDI, and common errors to avoid.
FDA Labeling Requirements: How They Differ from MDR
FDA labeling vs MDR compared side by side: what overlaps, what diverges, and whether a single label can serve both US and EU markets.
FDA Quality System Regulation (QSR) to QMSR Transition: What EU Startups Need to Know in 2026
The FDA has been harmonising its Quality System Regulation with ISO 13485 as the QMSR. Here is what EU startups need to know about the transition in 2026.
QMSR and ISO 13485: How the FDA Aligns with EU Standards
FDA QMSR ISO 13485 alignment explained: what changed, what stays FDA-specific, and how one QMS can serve both US and EU MDR markets.
FDA Clinical Data Requirements: IDE Studies and When You Need Them
FDA Investigational Device Exemption studies are how you generate clinical evidence for US submissions. Here is when an IDE is required and what it involves at a general level.
FDA Software Guidance: How US Software Regulation Differs from EU
FDA software regulation differs from MDR in pathway, documentation, and lifecycle. Here is the comparison for EU SaMD startups at general framing.
FDA and AI/ML: The Predetermined Change Control Plan Approach
The FDA's Predetermined Change Control Plan lets AI devices evolve within pre-approved boundaries. Here is how it compares to the MDR approach at general framing.
FDA Cybersecurity: Section 524B and Premarket Guidance
FDA cybersecurity Section 524B explained: SBOM, vulnerability handling, lifecycle plans, and how it compares to MDR cybersecurity expectations.
FDA UDI Requirements: GUDID Registration for EU Manufacturers
FDA UDI and GUDID for EU manufacturers: how GUDID differs from EUDAMED, dual submission, issuing entities, and the one-label strategy.
FDA Post-Market Requirements: MDR Reporting, Recalls, and Corrections
FDA postmarket obligations for EU manufacturers: Medical Device Reporting under 21 CFR 803, recalls and corrections under 21 CFR 806, compared to EU vigilance.
The US Agent Requirement: What EU Startups Need for FDA Compliance
Foreign manufacturers selling devices in the US must designate a US Agent to interact with FDA. Here is what the role does and how to choose one.
FDA Breakthrough Device Designation: Fast-Track for Innovation
FDA Breakthrough Device Designation explained for EU startups: eligibility, application, sprint discussions, priority review, and what it does not do.
FDA Emergency Use Authorization (EUA): Lessons from Crisis Response
What FDA Emergency Use Authorization is, when it applies, and how EU MedTech startups should think about it — including why MDR has no direct equivalent.
How to Choose a US Regulatory Consultant as an EU Startup
Practical guide for EU MedTech founders evaluating US regulatory consultants for 510(k), De Novo, PMA and QMSR work. Red flags, contracts, fees.
UK MHRA and UKCA Marking: Post-Brexit Medical Device Regulation in 2026
The UK regulates medical devices through the MHRA with UKCA marking (and continued CE recognition in transition). Here is where things stand in 2026 for EU startups.
Swiss Medical Device Regulation (MedDO): A Guide for EU Startups
Switzerland's MedDO mirrors MDR, but since the 2021 MRA expiry Switzerland is a third country. CH-REP, Swissmedic registration, dual-market reality.
Medical Device Regulation in Japan (PMDA): Guide for EU Startups
Japan's PMDA and PMD Act framework for EU MedTech founders: classification I-IV, MAH requirement, evidence expectations, sequencing vs CE mark.
Medical Device Regulation in China (NMPA): What EU Startups Need to Know
China's NMPA is a major but distinct medical device regulator. Here is what EU startups should know about market access at general framing.
Medical Device Regulation in Australia (TGA): A Guide for EU Startups
How EU MedTech startups enter Australia via the TGA: ARTG inclusion, sponsor model, classification, MDSAP route, and common surprises.
Medical Device Regulation in Canada (Health Canada): MDL and MDSAP
Health Canada MDL classes, mandatory MDSAP for Class II-IV, application contents, timelines, and why Canada gets cheaper if you're already MDSAP certified.
Medical Device Regulation in Brazil (ANVISA): Entering South America
How EU MedTech startups enter Brazil via ANVISA: classification, BRH sponsor, BPF inspection, MDSAP route, registration timelines, and Portuguese labelling.
Medical Device Regulation in South Korea (MFDS): APAC Access
South Korea MFDS medical device approval for EU startups: classification, KGMP audits, local representative, Korean clinical data expectations and timelines.
Medical Device Regulation in India (CDSCO): A Growing Market
India CDSCO medical device regulation for EU startups: A-D classification, Authorized Indian Agent, registration certificates, and realistic timelines.
Medical Device Regulation in Saudi Arabia (SFDA): Gulf Access
Saudi Arabia SFDA medical device regulation for EU startups: classification, Authorized Representative, MDNR registration, GCC cooperation, timelines.
The IMDRF and Global Harmonization: How International Frameworks Help Startups
The International Medical Device Regulators Forum creates harmonised guidance across jurisdictions. Here is what IMDRF is and how startups can use it strategically.
MDSAP: Using a Single Audit for Multiple Markets (US, Canada, Australia, Japan, Brazil)
MDSAP lets you satisfy five regulatory authorities with one audit. Here is what it is, what it covers, and when a MedTech startup should pursue it.
International Expansion Sequencing: Which Markets to Enter First After CE Marking
After CE marking, which country should you enter next? Here is a sequencing framework based on regulatory cost, market size, and strategic fit.
Regulatory Strategy for Global Market Access: Building a Scalable Compliance Framework
A global regulatory strategy is not a stack of country plans. It is a scalable framework where each market reuses the same evidence and QMS. Here is how to build one.
Country-Specific Registration: Hidden Costs of Expansion
Country-specific medical device registration costs nobody mentions in pitch decks: local reps, translations, fees, and how they compound across markets.
Import/Export Medical Devices: Customs and Free Sale Certificates
Medical devices import export customs free sale certificate guide: purpose, issuers, validity, customs codes, and common shipment failures.
Local Representatives and In-Country Agents by Market
Local representative medical device international guide: EU AR, US Agent, CH-REP, UKRP roles, contract essentials, single vs multi-market firms.
Translation Requirements for International Medical Device Registration
Translation requirements medical device international: what must be translated, by whom, at what cost, and the errors that blow up registrations.
How to Prioritize International Markets as a MedTech Startup with Limited Resources
Resource-limited startups cannot enter every market at once. Here is the prioritisation framework for MedTech international expansion.
The True Cost of International Market Access for MedTech Startups
True cost international market access medical device: a per-country budget framework applied to five markets, with registration, AR, translation and maintenance.
Common Mistakes EU Startups Make When Entering the US Market
EU MedTech startups make predictable mistakes when crossing the Atlantic. Here are the seven most common ones and how to avoid them.
International Market Access Checklist for MedTech Startups in 2027
The international market access checklist for MedTech startups in 2027: EU, US, UK, Canada, Australia, Japan — the regulatory checkpoints and cost reality for each.